Hualan Biological Engineering
002007.SZ
#3490
Rank
A$5.84 B
Marketcap
A$3.20
Share price
-0.76%
Change (1 day)
-11.02%
Change (1 year)
Hualan Biological Engineering Inc. is a Chinese pharmaceutical company that produces plasma products and vaccines.

Earnings for Hualan Biological Engineering (002007.SZ)

Earnings in 2025 (TTM): A$0.30 Billion

According to Hualan Biological Engineering's latest financial reports the company's current earnings are A$0.63 Billion. In 2024 the company made an earning of A$0.26 Billion a decrease over its 2023 earnings that were of A$0.41 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Hualan Biological Engineering from 2004 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) A$0.30 B13.03%
2024 A$0.26 B-36.03%
2023 A$0.41 B39.14%
2022 A$0.29 B-19.27%
2021 A$0.37 B-17.84%
2020 A$0.45 B37.54%
2019 A$0.32 B11.56%
2018 A$0.29 B50.74%
2017 A$0.19 B1.03%
2016 A$0.19 B23.54%
2015 A$0.15 B8.4%
2014 A$0.14 B10.91%
2013 A$0.12 B54.55%
2012 A$84.04 M-17.1%
2011 A$0.10 B-41.28%
2010 A$0.17 B6.13%
2009 A$0.16 B261.35%
2008 A$45.01 M85.72%
2007 A$24.23 M49.33%
2006 A$16.23 M56.91%
2005 A$10.34 M34.29%
2004 A$7.7 M